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Abstract
The modeling of complex biological systems presents a
significant challenge. Central to this challenge is striking
a balance between the degree of abstraction required to
facilitate analysis and understanding, and the degree of
comprehensiveness required for fidelity of the model to
its reference-system. It is likely necessary to utilize
multiple modeling methods in order to achieve this
balance. Our research created a hybrid simulation model
by melding an agent-based model of acute local infection
with a system dynamics model that reflects key systemic
properties. The agent based model was originally
developed to simulate global inflammation in response to
injury or infection, and has been used to simulate clinical
drug trials. The long term objective is to develop models
than can be scaled up to represent organ and system level
phenomena such as multiple organ failure associated with
severe sepsis. The work described in this paper is an
initial proof of concept of the ability to combine these two
modeling methods into a hybrid model, the type of which
will almost certainly be needed to accomplish the ultimate
objective of comprehensive in silico research platforms.
1.

INTRODUCTION

1.1. Problem statement and significance
An important new research frontier is the use of agent
based simulation (ABS) models and system dynamic (SD)
or differential equation (DE) models to study complex
biomedical phenomena such as the acute inflammatory
response (AIR) and its disordered states of systemic
inflammatory response syndrome (SIRS), multiple organ
failure (MOF) and sepsis [Neugebauer 2001 and
Vodovotz et al 2004].
SIRS/MOF is an important problem domain in
biomedical research [Buchman 1997, 2001].
It is
considered one of the most significant and prevalent
clinical problems in critical care medicine. SIRS/MOF is
a disease process that is a byproduct of the success of
initial therapies for infection and injury. It represents a
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behavioral region beyond the evolutionary “design
parameters” of the inflammatory response, as patients
previously suffering such a degree of initial insult would
have died prior to manifesting SIRS/MOF. It is
characterized by a systemic response to infection where,
even though the original infection may be eradicated by
the immune system and therapy, the collateral tissue
damage results in system failure. The phenomenon
involves interactions and feedback at multiple system
levels (molecular, cellular, tissue, and organ) such that the
complex interactions between components precludes the
attribution of the systemic response, and therefore its
control, to any single mediator or cell type. Since the
inflammatory response is ubiquitous the manifestation of
SIRS/MOF is distributed throughout the body’s tissues
and organs (hence Multiple organ failure), though the
prevalent organs involved are the lungs, gut, kidneys and
liver. While much has been learned in recent years, the
translation of basic science knowledge to effective
mechanism-based therapies for SIRS/MOF remains a
largely unsolved problem.
While both ABS and SD/DE methods are considered
to be complementary and appropriate for studying
problems such as SIRS/MOF, very little has been
published regarding hybrid approaches that integrate these
two important methods into a single model that retains
key advantages of each method and overcomes their
individual drawbacks.
For instance, ABS can be
computationally expensive and much less efficient than
SD/DE, whereas SD/DE requires the assumption of a
well-mixed system and may not handle spatial
heterogeneity as well as ABS. This paper presents an
initial effort towards the development of an interface
between ABS and SD/DE components within a single
hybrid model.
1.2. Background and brief review of the literature
Wakeland et al [2004] used SD and ABS to study
cellular receptor dynamics and compared the results from
each method. This research indicated that the two
paradigms are different and possess unique strengths and
weaknesses. Guidelines were provided for assessing
which of the two methods might be preferred in a given

situation. Both modeling paradigms were useful in
communicating two- and three- state equilibrium
(biochemical receptor) concepts. They are also useful in
forcing the researcher to ask questions regarding the rules
governing the system’s dynamics. The ABS model
allowed the researcher to question the rules at agent level
but was not as convenient for modeling a system with a
very large number of actors/agents when compared to the
SD model. Neither modeling tool however was superior
for obtaining new insights into receptor dynamics at the
level of complexity for which the specific system was
explored. The development of hybrid models was not
addressed in this paper.
One of the first studies to report the use of ABS to
model SIRS/MOF was An [2001].
This paper
synthesized a wide variety of basic science results into an
overall model that illustrated the complex dynamics seen
in the clinical environment. The underlying processes
(rules) were discussed in some detail, but the actual code
was not provided in this initial paper. In addition to
parametric variation, the degree of randomness could also
be easily varied. Many graphical results were presented,
some of which showed the behavior over time for
different cases, while others compared the results of
multiple runs with parameters being varied over a wide
range, or with parameters fixed but with many different
randomly generated cases. The paper was organized as a
biomedical basic science research paper to illustrate how
an in silico model could be used in the much the same
fashion as a traditional laboratory model.
A recent issue Critical Care Medicine included two
relevant papers on this topic [An 2004, Clermont et al
2004] as well as a short editorial article [Marshall 2004]
contrasting in silico modeling with in vivo and in vitro
research.
The editorial is both encouraging and
cautionary, warning that the potential benefits of these
new approaches rest heavily upon the correctness of
model algorithms and model data. It asserts that ABS
models have yet to prove themselves by predicting effects
that were not previously known.
An [2004] extends his earlier work, using the ABS
model of SIRS to conduct in silico experiments that
generally replicate the [disappointing] results of several
large-scale clinical trials of cytokine-directed antimediator agents. The author also evaluated several
hypothetical clinical trials, and found that they too would
be likely to not achieve statistically significant results. He
also showed how ABS models could be used to help
design more effective clinical trials. In addition to the
graphical and tabular results, extensive model details were
provided, including a link to a website containing the
actual model used to conduct the experiments.
Clermont et al [2004] developed a DE-based model
to study immunomodulatory strategies for treating cases

of severe sepsis. Their focus was to assess the feasibility
of using DE models to improve the design of clinical
trials. The model was used to simulate 1000 patients that
were subjected to various simulated treatments. The
results were presented in much the same fashion as results
would be presented from an actual clinical trial. This
research replicates in silico the general findings from
actual clinical trials--that it is very difficult to design a
treatment strategy that is effective over a broad range of
sepsis patients. The authors provide an appendix that
gives the model equations and parameters.
Other recent publications of interest include
Vodovotz et al [2004], which reviewed mathematical
models of the acute inflammatory response. This paper
emphasized the need for non-reductionist approaches, and
featured results from both An [2004] and Clermont et al
[2004]. The paper also looked closely at the validation
strategies used to assure the correctness of the model
logic and model data. Further, Vodovotz et al [2006]
outlined the process of model development as integrated
into general biomedical research. This paper was directed
primarily at the traditional “wet lab” research community,
but also outlined the process of integrated, iterative model
development for both ABS and SD/DE models in
conjunction with ongoing standard laboratory research.
2. RESEARCH METHODOLOGY
Our research was carried out in three phases. Phase I
consisted of reproducing An’s ABS model, and then
reducing it to facilitate parameter testing and improve
computation efficiency. Phase II attempted a similar
process with the Clermont et al ODE model. Phase III
involved developing a new SD/DE model using the same
modeling tool used by An to implement his ABS model
(Netlogo 2005), and a means of linking these two
submodels together. Inherent in Phase III was the
determination of the “interface edge” between the ABS
submodel and the SD submodel. The determination of
this “edge” has consequences with respect to the aspects
of model logic that are translated into the SD component,
as well as further implications for further development of
the resulting hybrid model.
2.1 Phase I
We used the Netlogo implementation of An’s 2004
SIRS model as a starting point. This model simulates
inflammation with interactions between endothelial cells
and circulating inflammatory cells at the blood/blood
vessel-lining interface. It is a 2-d grid torus ABS with the
grid populated with static endothelial cell agents, over
which move inflammatory cell agents. Injury or infection
is simulated as a spatially discrete pattern of endothelial
cell damage that can be varied by size. Therefore, at
initial perturbation there is portion of the ABS that is

“damaged” and a portion that is still “normal.” The
relative sizes of these areas changes as the system either
“heals” or progresses to “death.” Even though the ABS is
extremely abstract compared to reality, is still quite
complex, requiring 14 pages of procedures. There are 14
different “breeds” of agents representing different cell
types, each of which has unique logic. First, minor
differences between the logic documented in the paper
and the model provided on the web were rectified, and
then a variety of experiments were run in order to confirm
the prior results, and ascertain the feasibility and potential
value of creating a hybrid version of the model.
Observing the graphical display during several short
model runs indicated that most of the simulated tissue was
either healthy or severely “damaged,” with a “sharp”
boundary between the two regions. This suggested that
the model could probably be scaled down without loss of
utility. The area of the modeled region was scaled down
factor of 4. Also, the number of “cases” per experiment
was reduced from 100 to 10, and the time per run reduced
from 28 to 7 simulated days. Other minor changes were
also made, including modifying the logic so that the
iteration number would not be incorrectly reset to zero,
and to force the initial infection to be automatically
invoked for the first iteration instead of requiring the user
to remember to push a particular button at the start of the
run.
Sufficient experiments were run to reproduce the
results reported in Figure 1 of An [2004]. These were run
on multiple computers to reduce the total elapsed time.
The total elapsed computer time was nearly 30 hours.
The computers used included three laptops with processor
speeds varying from .4 to 1.2 GHz. The results clearly
showed the Initial Injury Number (IIN) values that
demark the lower and upper boundaries of the “region of
interest” (ROI) described by An [2004].
The next set of experiments required many more runs
than the first set, so it was necessary to further optimize
the model logic. The primary changes were: 1) reducing
small values of biochemical agents to zero in order to
lessen the number of calculations required in the diffusion
process, 2) moving the “divide OXY by 100” from inside
the SUM operation to outside the SUM, and 3) calculating
the SQRT function used in the injure-sterile and injureinfection procedures one time instead of calculating this
function IIN times for each iteration. These changes
speeded up model execution by a more than a factor of
two, dropping the computer time required to run the new
experiments from 70 to 30 hours.
Procedures were also added to facilitate experiments
that incrementally removed the effect of individual model
components and combinations of components. These
experiments test the impact of removing T-cells and Tcell germinators from the model. First, the five initial

values associated with T-cells were set to zero, one at a
time. Next, selected combinations of two or three initial
values were set to zero simultaneously. Finally, all five
initial values were set to zero. For each parameter set, 10
cases were simulated, for each of two different values of
IIN. The IIN values were chosen to reflect the lower and
upper bound of the ROI where the uncertainty in outcome
is the highest.
The data collection procedures provided within An’s
original model were not enhanced, leading to a degree of
experimental inefficiency. This was rectified later, as
described below.
2.2 Phase II
In preparation for adding SD/DE logic to the ABS
model, the DE model published by Clermont et al [2004]
was reviewed. This mechanistic model of an acute
inflammatory process was a systematic series of
differential equations one for each inflammatory
component chosen for simulation.
Each equation
describes the state level or concentration of components
and, based on the principle of mass-action, the
interactions of these components. Components were
selected for their accepted correlation to clinical
outcomes. Rate constants were extracted from the
pertinent literature or empirically determined to simulate
reported data.
An attempt was made to independently reproduce
their results by implementing the equations and
parameters provided in the appendix of the paper. We
entered the 18 differential equations and more than 80
constants into Matlab [2005]. A few minor typographical
errors in the published paper were corrected as seemed
most reasonable, and assumptions were made regarding
omitted values. We attempted to perform experiments
with this model by specifying values for the 11 floating
parameters and using Matlab’s DE solver to solve the
differential equations. However, despite interaction with
Clermont and his team we were never able to reproduce
the fundamental results. Since this was not the primary
thrust of our research we did not persist in this endeavor,
however, a significant benefit of this activity was
increasing our understanding about representing the target
system’s interactions in equation form.
2.3 Phase III
A hybrid model was created using the System
Dynamics tool within Netlogo. We use the term “edge”
for the interface and boundary between the ABS and SD
submodels. The determination of the “edge” can be made
on a series of system characteristics: structural,
behavioral, hierarchical, etc. To determine the “edge” in
this case we focused on those aspects of the biological

system that fell into either a local process or a systemic
process. Since the base ABS focused on the expansion of
an initial localized infection towards systemic effects, the
area of initial insult and subsequent interactions at this
point were left to the ABS. However, certain aspects of
the biological response, primarily related to the
production and life-cycle of circulating inflammatory
cells, occur “off-screen” from the ABS, and it was felt
that these dynamics could be better modeled using a
SD/DE methodology. Accordingly, we implemented a
simple DE submodel that focused on systemic
polymorphoneutrophils (PMN) production, maturation,
sequestration, and release. This submodel had three state
variables: PMNs_mature_marrow, PMNs_circ, and
PMNs_sequestered. Many of the flows between these
compartments were modeled strictly within the SD
submodel, but others were influenced by the conditions

within the ABS submodel. Figure 1 shows the flow
diagram for the SD submodel. Additional integration
between the SD and ABS submodels included
modifications to the logic in the ABS submodel regarding
the creation of PMNs. In the purely ABS version of the
model, the logic was to randomly generate PMNs at a rate
the corresponded to the need. In the hybrid model, the
“availability” of PMNs (modeled in the DE submodel)
was used to modulate the PMN creation rate with the
ABS submodel. In the SD submodel, the maturation of
PMNs was influenced by total granulocyte colony
stimulating factor (GCSF) from the ABS model. The
primary role of the SD model was to manifest a delay
between the elevation of the cytokines and the increase in
PMNs. The experiments described previously were then
rerun using the hybrid model. Further details of this
model may be found in Wakeland et al [2006].

A

B

Figure 1: Flow diagram of the system dynamics submodel, showing the compartments and their interconnections. Inflammatory responsive
cells, in this case polymorphic neutrophils (PMNs), are produced and mature in the bone marrow (PMNs_mature_marrow). These are
released into general circulation (PMNs_circ) at a basal rate, which is responsive to chemical signals produced elsewhere in the body.
Circle A highlights the location of feedback from the inflammatory process represented by the agent-based model. PMNs are sequestered
(PMNs_sequestered) from circulation by local chemical signals and attractants produced locally by the inflammatory process. Circle B
highlights the location of feedback (the transition of circulating PMNs into inflammatory tissue) to the agent-based model. Emigration of
PMNs is the “normal” homeostatic loss of PMNs to other tissues.

3. RESULTS
3.1 Phase I Results
Figure 2 shows the initial experimental results using
the ABS model. The x-axis indicates the initial injury
number IIN, from 0 to 1000. For each value of IIN two
points are shown, the end infection (EIN) and the end
oxygen deficit (EOD), where end refers to the end of the
simulation run (considered to be one week after the initial
injury/infection in our case vs. four weeks used by An).
Each point represents the result from one of the 10

simulated cases. The mean values for each of these 10
cases is also shown, in a larger font, with line segments
connecting these points. When IIN is small, both the
mean EOD and mean EIN are also small, indicating a
favorable prognosis. When IIN is very large, both EOD
and EIN are large, indicating an almost certain
unfavorable outcome. An [2004] describes the center
region of Figure 2 as the “region of interest,” where EIN
is small, but EOD remains large. In this region, the
inflammatory response has ameliorated the initial
infection, but the “collateral damage” to otherwise normal
tissue prevents recovery.

Figure 2: Reproduction of the “Region of Interest” (An 04). The left hand curve shows the mean value of end oxygen deficit for each given
value of Initial Injury (IIN). Each mean value is calculated from 10 cases (runs) for each particular value of IIN. The individual values for
each case are also shown as a scatter-plot. The right hand curve is similar, but shows the end injury number (EIN) for the corresponding
IIN values. The region of interest is between the two curves.

Figure 3. Graph A shows the end oxygen deficit (EOD) and graph B shows the end injury number (EIN) for each of 14 different sets of
parameter values. 10 simulated cases are shown for each parameter set and for each of the two values for initial injury (IIN).

Figure 3 shows the results of the second set of
experiments focusing on the effects of the T-cell
components. Parameters associated with T-cells were
varied significantly, essentially “turning off” their proinflammatory and/or anti-inflammatory effects. Ten cases
were run for each set of parameter values. Figure 3A
shows EOD when IIN = 150, near the left hand boundary
of the region of interest (see Figure 2).
Figure 3B shows EIN when IIN = 700, which is near
the right hand boundary of the region of interest. One
might expect that the pattern of outcomes in terms of

EOD and EIN would be correlated to some degree with
which set of parameters was used. However, as can be
seen in Figure 3 the overall impact of these particular
processes is essentially “lost in the noise,” since the
variation in the results for a given set of parameter values
is much larger than the variation between different sets of
parameter values. When IIN = 150, EIN is near the
minimum in all cases, and when IIN = 700, EOD is at the
maximum in all cases; hence graphical results for these
experiments are not shown.

Statistical tests of the data shown in Figure 3
indicated that the hypothesis that these samples were all
drawn from the same population cannot be rejected
(p<.05). Therefore, the removal of the T-cell effects did
not appear to have a statistically significant effect.
A subjective result from Phase I was the sense that
the ABS model may be unnecessarily complex. The fact
that it takes many hours or even days to run a full set of
experiments limits the practical utility of such a model, an
acknowledged drawback of ABS. The high degree of
complexity also makes it difficult to assure that the logic
matches the modeler’s intent, much less reality.
However, a major strength of the ABS model is its
transparency—it shows exactly how the researcher
believes that the various mechanisms actually work. We
will address the implications of the balance between these
two issues in the discussion.
3.2 Phase II Results
No objective results were produced in Phase II.
However, the experience demonstrated the difficulty in
utilizing prior published papers and models, particularly
in systems with very complex dynamics. The complexity
of the resulting models represents a significant barrier for
other researchers to overcome in order to replicate, and,
ideally, extend published results.

Testing the hybrid model prompted a sequence of
modifications in the hybrid logic, and revealed problems
with the model scaling that was done in Phase I. This was
corrected, and the experiments were rerun. Figure 4
shows a recreation of Figure 2 using the hybrid model
results. The mean values from the ABS model (Figure 2)
are also shown for comparison. The results are very
similar, except that slope of the EOD graph is steeper for
the hybrid model.
The hybrid model was then used to rerun the 14
parameter set experiment from Phase I. The results are
shown in Figure 5. Only one graph is shown, EIN with
IIN=700, for comparison to Graph B from Figure 3. In
Figure 5, most of the points are located at the extreme
values for EIN, whereas in Figure 3, Graph B, this is not
the case. The results for EOD are not shown in Figure 5
because they do not differ appreciably from Figure 3,
Graph A.
4. DISCUSSION
This study demonstrated that the use of agent based
simulation modeling, system dynamics modeling, and
differential equation-based modeling is not only
complementary, as had been suggested by others, but can
in fact be unified into a single hybrid model, with the
benefit of able to optimize the balance between the
strengths and weaknesses of each method.

3.3 Phase III Results

Figure 4. Comparison of hybrid model results (Region of Interest) with ABS model results from Phase I. The solid line with hollow
squares indicates the mean ending oxygen deficit (EOD) vs. initial injury number (IIN). The smaller hollow squares show the results from
each of ten runs from which the mean was computed. The solid line with diamonds shows the mean ending injury number (EIN) vs. IIN,
with the smaller diamonds showing the results for individual runs. The dashed lines show the mean values from the ABS model runs for
comparison (taken directly from Figure 2).

.

Figure 5. Results of running the 14 parameter sets experiment
using the hybrid model. The results are shown only for EIN with
IIN=700 because they differ appreciably from Figure 3, whereas
the results using the hybrid model for EOD with IIN=150 look
exactly the same.

Phase I results indicate that some aspects of the
original ABS model may not impact the primary
behavioral responses to the degree seen clinically.
Specifically, the lack of effect of completely removing Tcells suggests that further work is needed to verify that the
logic correctly captures the phenomena to an appropriate
degree of approximation.
Phase II results underscore how difficult it is for
biomedical researchers to replicate and on the work of
others, even with full disclosure of all aspects of the prior
research and full cooperation of the original research
team.
Phase III results show that differential equations,
specified using system dynamics (SD) notation, can be
easily added to an ABS model implemented in Netlogo,
and that the resulting submodel can be integrated easily
into the ABS logic and vice versa. The behavior of the
AIR model with a simple SD submodel replacing some of
the agent-based logic was nearly identical to the behavior
of the pure ABS model. The region of interest (Figure 2)
was modified only slightly (Figure 4) in that the slope of
the EOD as a function of the initial injury becomes
steeper. One possible explanation for this result is that
since the SD submodel is deterministic, and it replaced a
portion of the ABS model that was stochastic, the overall
uncertainty of the response became smaller, and thus the
transition from recovery to non-recovery as a function of
initial injury occurred more rapidly.
Challenges in the present study included the high
degree of complexity in both the ABS model and the
published DE model. This complexity made it very
difficult to achieve a high degree of confidence that the
model
logic/equations/parameters
were
correctly
implemented. The ABS and DE models provided by the
original researchers both contained errors or other types
of discrepancies, from missing parentheses to equations

with entirely different terms. It was necessary to correct
these inconsistencies before the primary research
activities could commence.
The high degree of
complexity also dramatically increased the time required
to run experiments with the ABS model and the hybrid
model.
One conclusion we reached is that researchers should
strive to find ways to reduce the complexity of their
models to the irreducible minimum. The present research
suggests that both the ABS model and the hybrid model
contain non-essential components. The problem with this
is not simply that the models contain logic or variables
that are superfluous and can be ignored. Rather, these
additional components may actually be a liability because
they obscure important relationships and make it much
more difficult for other researchers to confirm and/or
extend the research.
There is, however, also recognition of the potential
pitfalls in the selection of modeling ontologies if
“efficiency” and “simplicity” are the overarching
modeling goals, particularly in systems as complex as the
inflammatory response. One of the benefits of using
models to study the AIR is the ability of
mathematical/simulation models to function as tools for
knowledge representation and integration. A major
difficulty in current attempts to characterize the AIR is
the sheer volume of mechanistic data present; it is
virtually impossible to determine which aspects of the
system are “critical” and which areas are not. In fact, it is
most likely that it is combinations and clusters of cells
and mediators that are the true determinants of system
behavior, rather than individual mediators or cell types.
Therefore, at least initially models of the AIR need to be
quite inclusive and comprehensive, even at the initial
expense of efficiency and simplicity. However, through
reductive processes as demonstrated in this paper, some
degree of determination of “criticality” may be
accomplished by manipulation of the in silico mirror of
the reference system, thus leading to insights with respect
to the reference system that may have implications for
more traditional laboratory research by identifying
potential targets for manipulation.
Our results suggest that caution should be exercised
in the interpretation of the behavior of these models with
respect to clinical practice. The parameter changes tested
using the ABS model could have easily represented the
potential impact of a pharmacological intervention.
However, the research also demonstrated that the impact
of other variations appear to almost entirely mask the
potential impact of this type of targeted intervention.
While the idea of in silico clinical trials is very intriguing,
much more research is called for. Parameter testing of the
type we have shown should be a necessary component in
the analysis of these models, not only to delineate the

“true” effect of an intervention, but to also facilitate the
criticality determination of the system’s components as
described above. Given these cautions, it should be
emphasized that the use of these mathematical modeling
techniques are not intended as replacements for standard
methods of biomedical research, but rather are intended to
be adjuncts to the general research process.
The present study was exploratory in nature, and
focused on a single ABS model and its extension to a
hybrid version. Consequently, these findings are only
suggestive in nature; further examination of multiple
examples from multiple modeling disciplines is
warranted. The concept of “articulated” models involving
multiple, interchangeable components has been raised by
Ropella et al [2005] as a means of advancing model
design and use. In this manuscript we use the term
“edge” to refer to this articulating interface, “edge” as
opposed to “point” insomuch the interface is multidimensional, “edge” as opposed to “surface” as “edge”
connotes, simultaneously, both a boundary and a
transition. We believe that the general application of
modeling to biomedical research will be greatly enhanced
by the development of hybrid models that will utilize the
respective advantages of different modeling methods.
Specific opportunities for further research suggested
by the present research include: 1) creating a simplified
version of the model that retains its behavioral richness,
2) the combination of different ABS submodels
representing specific organs linked together within an SD
“wrapper” to simulate organ-organ crosstalk and total
body behaviors, 3) the identification and investigation of
different “edges” of ABS and SD/DE interfaces that
would best utilize the respective strengths of each
method, and 4) the development of a means of
dynamically “shifting” the edge between the ABS and the
SD/DE submodels with the intent of improving
computational efficiency in large scale models.
5.
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